[Treatment of depressive disorders].
Saiz Ruiz
J
J
Servicio de Psiquiatría, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid.
Ibáñez Cuadrado
A
A
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D000075202:Contraindications; D003866:Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010789:Phototherapy; D011320:Primary Health Care; D011575:Psychoanalytic Therapy; D011613:Psychotherapy; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D009638:Norepinephrine
Tratamiento de los trastornos depresivos.